Press Release

Preeclampsia Therapeutics Market to Grow as Incidence of Chronic Diseases Rises: Fortune Business Insights

Global Preeclampsia Therapeutics Market to Gain Traction; NHS Announces Plan for Rapid Diagnosis of Preeclampsia Via an Advanced Blood Test: Fortune Business Insights

Increasing spread of preeclampsia worldwide will be the key driver of the global preeclampsia therapeutics market growth during the forecast period. Preeclampsia refers to a condition wherein a woman experiences high blood pressure during or after pregnancy.

There may also occur low clotting factors, indicating problems of the liver or kidneys. The most potential causes identified by doctors for this condition are autoimmune disorders, genetic factors, and blood vessel issues. According to the Maternal Health Task Force under the Harvard Chan School, preeclampsia kills around 76,000 mothers and 500,000 babies globally every year. Moreover, in low and middle income countries, preeclampsia causes 16% of maternal deaths. This rising prevalence of the disorder will spur the demand for preeclampsia therapeutics and favor the growth of the global preeclampsia therapeutics market in the forecast period.

Fortune Business Insights identifies some of the major competitors in the global preeclampsia therapeutics market:

  • Hoffmann-La Roche Ltd.
  • Sera Prognostics
  • Pluristem Therapeutics Inc.
  • AMAG Pharmaceuticals
  • A1M Pharma AB
  • PerkinElmer Inc.
  • VG Lifesciences

Intensive Research and Collaborations to Characterize Market Competition

Most of the key players in the global preeclampsia therapeutics market competition are doubling down their investment in research to come out with new solutions to diagnosing and treating preeclampsia. For instance, PerkinElmer invested in Foetal Medicine Foundation’s Project ASPRE study in June 2017, which found that delivering low-dose aspirin can lead to bring down the rate of pre-term preeclampsia by 62%. Some companies are also entering into strategic partnerships with other players to diversify their product offerings. For example, in September 2018, AMAG Pharmaceuticals and Velo Bio joined hands to develop and market a polyclonal antibody, digoxin immune Fab (ovine) (DIF), to treat severe preeclampsia in pregnant women.

More Trending Topics From Fortune Business [email protected]

Peripheral Vascular Interventions Market Is Forecast to Rise; By Top Key Vendors | Edwards Lifesciences Corporation, Cardinal Health, TERUMO CORPORATION, C. R. Bard, Inc.

Veterinary Orthopedic Implants Market to Rise at a Healthy CAGR | Top Key Players are DePuy Synthes, B. Braun Melsungen AG, Fusion Implants, Integra LifeSciences, Orthomed (UK) Ltd

About us: 

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *